APA (7th ed.) Citation

Ramjee L, Vurgun N, Ngai C, Patel M, & Tremblay G. (2023). Cost-Effectiveness Analysis of Nefecon versus Best Supportive Care for People with Immunoglobulin A Nephropathy (IgAN) in the United States. Dove Medical Press.

Chicago Style (17th ed.) Citation

Ramjee L, Vurgun N, Ngai C, Patel M, and Tremblay G. Cost-Effectiveness Analysis of Nefecon Versus Best Supportive Care for People with Immunoglobulin A Nephropathy (IgAN) in the United States. Dove Medical Press, 2023.

MLA (9th ed.) Citation

Ramjee L, et al. Cost-Effectiveness Analysis of Nefecon Versus Best Supportive Care for People with Immunoglobulin A Nephropathy (IgAN) in the United States. Dove Medical Press, 2023.